Fair Pricing of Innovative Medicines: An EHA Position Paper

Department of Hematology, Amsterdam University Medical Centers, Amsterdam, The Netherlands Barts Cancer Institute, Queen Mary University of London, London, UK Medical University of Vienna, Department of Medicine I, Division of Hematology and Hemostaseology, and Comprehensive Cancer Center, Vienna, Austria Inspire2Live, Amsterdam, The Netherlands Amyloidosis Research and Treatment Center, Foundation IRCCS Policlinico San Matteo, University of Pavia, Italy PNH Support, a Charitable Incorporated Organization registered with the Charities Commission of England and Wales (no. 1161518), London, UK Erasmus School of Health Policy and Management, Erasmus University, Rotterdam, The Netherlands Institute for Medical Technology Assessment, Rotterdam, The Netherlands European Hematology Association, The Hague, The Netherlands. Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NCND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. HemaSphere (2020) 4:5(e488). http://dx.doi.org/10.1097/ HS9.0000000000000488. Received: 19 August 2020 / Accepted: 20 August 2020 The problem